An out-of-session meeting was held on 25 August 2014 to discuss the PBS listing of eculizumab (Soliris) for patients with atypical haemolytic uraemic syndrome. A PBAC outcome statement is available on the PBS website.

For more details, go to: http://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/pbac-outcomes/2014-08/pbac-recommendation